Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.19

+1.8%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: greedsgd_2000 who wrote (1786)	10/4/2000 1:54:45 PM
From: Biomaven	Read Replies (2) of 52153

I think it's more likely the steady stream of large offerings by the first/second tier that's to blame for the sector's recent performance, combined with some downgrades like that of MEDI. Pharma is basically flat today, and if it was the debate they'd be down as well. Seems like every day we get hit with yet another few- hundred-million dollar offering. There's also the IMNX offering in the background. With all this extra money in the hands of the biotechs, Rick's trickle-down strategy is starting to look better and better. They can't spend it all on fancy furnishing for their offices (I hope <g>). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next